Terms: = Breast cancer AND DDB2, Q92466, 1643, ENSG00000134574, FLJ34321
37 results:
1. Association of low-dose ionising radiation with site-specific solid cancers: Chinese medical X-ray workers cohort study, 1950-1995.
Gu Y; Wang J; Wang Y; Xu C; Liu Y; Du L; Wang Q; Ji K; He N; Zhang M; Song H; Niu K; Liu Q
Occup Environ Med; 2023 Nov; 80(12):687-693. PubMed ID: 37918914
[TBL] [Abstract] [Full Text] [Related]
2. HER2 Status Assessment in Endometrial Serous Carcinoma: Comparative Analysis of Two Proposed Testing and Interpretation Algorithms.
Hashem S; Zare SY; Fadare O
Int J Gynecol Pathol; 2024 Jan; 43(1):4-14. PubMed ID: 37406350
[TBL] [Abstract] [Full Text] [Related]
3. Four Genes Predictive for the Severity of Hematological Damage Reveal a Similar Response after X Irradiation and Chemotherapy.
Schüle S; Bristy EA; Muhtadi R; Kaletka G; Stewart S; Ostheim P; Hermann C; Asang C; Pleimes D; Port M; Abend M
Radiat Res; 2023 Feb; 199(2):115-123. PubMed ID: 36480042
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-inducible CircPFKFB4 Promotes breast cancer Progression by Facilitating the CRL4
Chen H; Yang R; Xing L; Wang B; Liu D; Ou X; Deng Y; Jiang R; Chen J
Int J Biol Sci; 2022; 18(9):3888-3907. PubMed ID: 35813480
[TBL] [Abstract] [Full Text] [Related]
5. Prediction of Overall Survival Among Female Patients With breast cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract] [Full Text] [Related]
6. Depletion of DNA damage binding protein 2 sensitizes triple-negative breast cancer cells to poly ADP-ribose polymerase inhibition by destabilizing Rad51.
Zhao L; Si CS; Yu Y; Lu JW; Zhuang Y
Cancer Sci; 2019 Nov; 110(11):3543-3552. PubMed ID: 31541611
[TBL] [Abstract] [Full Text] [Related]
7. Multi-gene assays: effect on chemotherapy use, toxicity and cost in estrogen receptor-positive early stage breast cancer.
Hochheiser L; Hornberger J; Turner M; Lyman GH
J Comp Eff Res; 2019 Apr; 8(5):289-304. PubMed ID: 30663337
[TBL] [Abstract] [Full Text] [Related]
8. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract] [Full Text] [Related]
9. Effect of reduction mammoplasty on acute radiation side effects and use of lumpectomy cavity boosts.
Lin JY; Bluebond-Langner R; Choi E; Cheston S; Nichols EM; Cohen RJ; Bentzen SM; Drogula C; Kesmodel S; Bellavance E; Rosenblatt P; Tkaczuk K; Slezak S; Feigenberg SJ
Pract Radiat Oncol; 2017; 7(5):e299-e308. PubMed ID: 28214145
[TBL] [Abstract] [Full Text] [Related]
10. ddb2 (damaged-DNA binding 2) protein: a new modulator of nanomechanical properties and cell adhesion of breast cancer cells.
Barbieux C; Bacharouche J; Soussen C; Hupont S; Razafitianamaharavo A; Klotz R; Pannequin R; Brie D; Bécuwe P; Francius G; Grandemange S
Nanoscale; 2016 Mar; 8(9):5268-79. PubMed ID: 26879405
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variations in vitamin D-related pathways and breast cancer risk in African American women in the AMBER consortium.
Yao S; Haddad SA; Hu Q; Liu S; Lunetta KL; Ruiz-Narvaez EA; Hong CC; Zhu Q; Sucheston-Campbell L; Cheng TY; Bensen JT; Johnson CS; Trump DL; Haiman CA; Olshan AF; Palmer JR; Ambrosone CB
Int J Cancer; 2016 May; 138(9):2118-26. PubMed ID: 26650177
[TBL] [Abstract] [Full Text] [Related]
12. breast cancer after prophylactic mastectomy (bilateral or contralateral prophylactic mastectomy), a clinical entity: presentation, management, and outcomes.
Mutter RW; Frost MH; Hoskin TL; Johnson JL; Hartmann LC; Boughey JC
Breast Cancer Res Treat; 2015 Aug; 153(1):183-90. PubMed ID: 26210521
[TBL] [Abstract] [Full Text] [Related]
13. The contributions of breast density and common genetic variation to breast cancer risk.
Vachon CM; Pankratz VS; Scott CG; Haeberle L; Ziv E; Jensen MR; Brandt KR; Whaley DH; Olson JE; Heusinger K; Hack CC; Jud SM; Beckmann MW; Schulz-Wendtland R; Tice JA; Norman AD; Cunningham JM; Purrington KS; Easton DF; Sellers TA; Kerlikowske K; Fasching PA; Couch FJ
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25745020
[TBL] [Abstract] [Full Text] [Related]
14. Candidate gene analysis of BRCA1/2 mutation-negative high-risk Russian breast cancer patients.
Sokolenko AP; Preobrazhenskaya EV; Aleksakhina SN; Iyevleva AG; Mitiushkina NV; Zaitseva OA; Yatsuk OS; Tiurin VI; Strelkova TN; Togo AV; Imyanitov EN
Cancer Lett; 2015 Apr; 359(2):259-61. PubMed ID: 25619955
[TBL] [Abstract] [Full Text] [Related]
15. Chemotherapy-induced peripheral neuropathy and its association with quality of life: a systematic review.
Mols F; Beijers T; Vreugdenhil G; van de Poll-Franse L
Support Care Cancer; 2014 Aug; 22(8):2261-9. PubMed ID: 24789421
[TBL] [Abstract] [Full Text] [Related]
16. The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies.
Hannah J; Zhou PB
Chin J Cancer; 2013 Sep; 32(9):478-82. PubMed ID: 23845142
[TBL] [Abstract] [Full Text] [Related]
17. ddb2: a novel regulator of NF-κB and breast tumor invasion.
Ennen M; Klotz R; Touche N; Pinel S; Barbieux C; Besancenot V; Brunner E; Thiebaut D; Jung AC; Ledrappier S; Domenjoud L; Abecassis J; Plénat F; Grandemange S; Becuwe P
Cancer Res; 2013 Aug; 73(16):5040-52. PubMed ID: 23774208
[TBL] [Abstract] [Full Text] [Related]
18. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
[TBL] [Abstract] [Full Text] [Related]
19. BRCA1 and p53 regulate critical prostate cancer pathways.
De Luca P; Moiola CP; Zalazar F; Gardner K; Vazquez ES; De Siervi A
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):233-8. PubMed ID: 23670255
[TBL] [Abstract] [Full Text] [Related]
20. Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.
Manohar K; Mittal BR; Bhoil A; Bhattacharya A; Singh G
Nucl Med Commun; 2013 Jun; 34(6):557-61. PubMed ID: 23549551
[TBL] [Abstract] [Full Text] [Related]
[Next]
